11 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... #Metformin #CKD3 ... #CKD4 #Dosing # ... Pharmacology #VisualAbstract
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Prescribing and Dosing ... in CKD Dose Initiation ... #Prescribing #Dosing ... #CKD #pharmacology ... #algorithm #diabetes
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
(stage IV or V CKD ... including most type 1 diabetics ... including most 2 diabetics ... Weight #Based #pharmacology ... endocrinology #diabetes
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... patients with Type 1 diabetes ... or Type 2 diabetes ... evidence-based pharmacologic ... #Diabetes #CKD #
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm
Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
function (eGFR < 60 ml ... Family history, ultrasound ... Proteinuria) • Diabetes ... Hyperphosphatemia #CKD
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... Lithium-induced nephrogenic diabetes ... DDAVP) • Central diabetes ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... patients with CKD ... , HF, or diabetes ... #Hyperkalemia #Pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology #